Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5127]

Phase I study of duvelisib in patients with relapsed or refractory CLL

Dr Susan O’Brien – University of California, Irvine, California, USA

$Phase I study of duvelisib in patients with relapsed or refractory CLL ( Dr Susan O’Brien – University of California, Irvine, California, USA )$

The LRF CLL4 trial: long-term outcomes

Prof Daniel Catovsky - The Institute of Cancer Research, London, UK

The LRF CLL4 trial: long-term outcomes ( Prof Daniel Catovsky - The Institute of Cancer Research, London, UK )

Expert panel discussion: The best of iwCLL 2015

Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai

Expert panel discussion: The best of iwCLL 2015 ( Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai )

Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells

Dr Alexey Danilov - Oregon Health and Science University, Portland, USA

Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells ( Dr Alexey Danilov - Oregon Health and Science University, Portland, USA )

Genetic deletions in CLL

Dr Carlo Croce - The Ohio State University College of Medicine, Columbus, USA

Genetic deletions in CLL ( Dr Carlo Croce - The Ohio State University College of Medicine, Columbus, USA )

Ethnic variations in CLL prevalence

Dr Thomas Chan - Queen Mary Hospital, Hong Kong, China

Ethnic variations in CLL prevalence ( Dr Thomas Chan - Queen Mary Hospital, Hong Kong, China )

Risk of bleeding-related adverse events in ibrutinib treated CLL patients

Dr Adrian Weistner - National Heart, Lung and Blood Institute, Maryland, USA

Risk of bleeding-related adverse events in ibrutinib treated CLL patients ( Dr Adrian Weistner - National Heart, Lung and Blood Institute, Maryland, USA )

Crystallography of the B-cell receptor immunoglobulin in CLL patients

Prof Paolo Ghia - San Raffaele University, Milan, Italy

Crystallography of the B-cell receptor immunoglobulin in CLL patients ( Prof Paolo Ghia - San Raffaele University, Milan, Italy )

Epidemiology of CLL: Interlymph consortium and genome-wide sequencing studies

Prof Claire Vajdic - University of New South Wales, Sydney, Australia

Epidemiology of CLL: Interlymph consortium and genome-wide sequencing studies ( Prof Claire Vajdic - University of New South Wales, Sydney, Australia )

Harmonisation of CLL diagnosis and detection of residual disease monitoring by...

Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK

Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry ( Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK )

Results of subgroup analysis of the HELIOS trial

Dr Paula Cramer – University of Cologne, Cologne, Germany

Results of subgroup analysis of the HELIOS trial ( Dr Paula Cramer – University of Cologne, Cologne, Germany )

Primary results from the MABLE phase IIIb study

Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France

Primary results from the MABLE phase IIIb study ( Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France )

More from ecancer